Secular Trends in Use of Disease Modifying Anti-Rheumatic Drugs for the Treatment of Rheumatoid Arthritis in the United States

被引：0
|
作者：
Desai, Rishi J. [1 ]
Solomon, Daniel H. [2 ]
Liu, Jun [3 ]
Kim, Seoyoung C. [4 ]
机构：
[1] Brigham & Womens Hosp, PharmacoEpidemiol & PharmacoEcon, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2725
引用
收藏
页数：2
相关论文
共 50 条
  • [1] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
    Roussy, J. P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Legare, J.
    Lachaine, J.
    VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
  • [2] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
    Roussy, Jean-Pascal
    Bessette, Louis
    Bernatsky, Sasha
    Rahme, Elham
    Legare, Jean
    Lachaine, Jean
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [3] USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND RISK OF MULTIPLE MYELOMA IN RHEUMATOID ARTHRITIS
    Tokareva, Y.
    Peterson, A.
    Baraff, A.
    Smith, N.
    Coffey, D.
    Weiss, N.
    Singh, N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP642 - NP643
  • [4] Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Garrood, T
    Scott, DL
    BIODRUGS, 2001, 15 (08) : 543 - 561
  • [5] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
  • [6] Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
    Toby Garrood
    David L. Scott
    BioDrugs, 2001, 15 : 543 - 561
  • [7] SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS ON THE TREATMENT WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, E.
    Ito, S.
    Kurosawa, Y.
    Taniguchi, S.
    Kobayashi, D.
    Abe, A.
    Otani, H.
    Nakazono, K.
    Murasawa, A.
    Narita, I.
    Ishikawa, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 985 - 985
  • [8] Treatment Patterns with Disease Modifying Anti-rheumatic Drugs in United States Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Overbury, Rebecca
    Pei, Shaobo
    Penmetsa, Gopi
    Sauer, Brian
    Patil, Vikas
    Walker, Jodi
    Clewell, Jerry
    Douglas, Kevin
    Clegg, Daniel
    Cannon, Grant
    Halwani, Ahmad
    Walsh, Jessica
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] TREATMENT PATTERNS WITH DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN UNITED STATES VETERANS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Walsh, Jessica A.
    Pei, Shaobo
    Penmetsa, Gopi
    Sauer, Brian
    Patil, Vikas
    Walker, Jodi
    Clewell, Jerry
    Douglas, Kevin
    Clegg, Daniel
    Cannon, Grant
    Halwani, Ahmad
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 608 - 609
  • [10] Use of disease-modifying anti-rheumatic drugs and cardiovascular events in patients with rheumatoid arthritis
    Kaminski, Matthew
    Shishehbor, Mehdi H.
    Gutierrez, Antonio
    Amini, Mohammad R.
    Coats, Walter
    Moghbelli, Meisam
    Askari, Arman T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A370 - A370
12345